#PCR and Real-time PCR Molecular Diagnostics Market Scope

[mitalipingale]

The PCR and Real-time PCR Molecular Diagnostics Market in 2023 is US$ 5 billion, and is expected to reach US$ 7.01 billion by 2031 at a CAGR of 4.30%.

[soumyafwr]

PCR and Real-time PCR Molecular Diagnostics Market Size, Analysis and Forecast 2031

[creativeera]

Point of Care Diagnostics: Revolutionizing Healthcare with Real-Time Testing

The Advent of Quick and Accurate Medical Testing Point of Care Diagnostics have emerged as a groundbreaking development in the medical field by enabling accurate testing to be done quickly and conveniently. Traditional diagnostic methods usually require samples to be sent to a centralized laboratory for analysis, which can delay vital treatment decisions by several days. However, point-of-care tests provide results within minutes using portable devices, bringing testing closer to the patient. This revolutionary approach is transforming healthcare delivery. Rapid Testing for Better Patient Outcomes By facilitating timely diagnosis, point-of-care testing leads to better patient outcomes. Speedy detection of conditions like infections or chronic diseases allows doctors to prescribe appropriate treatment without delay. For example, point-of-care tests are commonly used in emergency rooms to quickly identify heart attacks, strokes or life-threatening infections. Getting fast diagnostic results is crucial for such medical emergencies as it ensures patients receive the right therapy as soon as possible. The timely administration of antibiotics, anti-clotting medications or other critical treatments improves survival rates and recovery. Patient Comfort and Convenience Besides clinical benefits, Point of Care Diagnostics enhance patient comfort and convenience. People no longer have to wait anxiously for days to learn about their health while potentially worsening conditions go untreated. With devices that analyze samples on-site, patients get actionable results during the same clinical visit when treatment decisions are made. This spares them follow-up trips to the doctor or lab and unnecessary stress. Home testing using self-administered point-of-care kits even allows monitoring health remotely while maintaining independence. Finger-prick blood samples or urine specimens are all that's needed, eliminating difficulties obtaining specimens. More Efficient Use of Resources Speedy diagnostic testing optimizes use of limited healthcare resources. Quick turnaround times avoid unnecessary reliance on expensive treatments initiated just to address uncertainty in diagnoses. Point-of-care devices reduce laboratory workloads too by decentralizing testing. Moreover, decentralized testing is vital for resource-constrained settings like rural areas, refugee camps or developing countries where access to centralized labs is limited. Portable devices overcome infrastructure barriers and enable basic medical services even in remote areas. This promotes healthcare equity globally. A Proliferation of Diagnostic Platforms Rapid technological progress has enabled the development of varied point-of-care testing systems. Examples include paper microfluidic devices, electrochemical sensors, molecular diagnostics platforms and portable ultrasound machines integrated with imaging analysis software. Immunology-based tests detecting proteins or antibodies through lateral flow or microarray methods are commonly used for conditions like infections and cardiac markers. Molecular diagnostic platforms employ techniques like polymerase chain reaction (PCR) for swift nucleic acid amplification and analysis of viruses or genetic markers. Newer technologies like CRISPR gene editing also hold promise as a basis for point-of-care genetic testing. With ongoing research, the types of conditions examinable at the point of care continue expanding in scope and complexity. Get more insights on Point Of Care Diagnostics

Also read related article on Gastroesophageal Reflux Disease Treatment Devices Market

For Deeper Insights, Find the Report in the Language that You want

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[marketingreportz]

Companion Diagnostics Market - Forecast(2024 - 2030)

 Companion Diagnostic Market Overview:

The Harvard University, while addressing the risk associated with reactions of new drugs prescription, has stated some overwhelming facts. According to their findings, even properly prescribed drugs causes about 1.9 million hospitalizations a year and about 128,000 people die from drugs prescribed to them.[1] Such epidemic condition is being tailgated by the need of safe and effective and specific use of the drug. Owing to such demands, companion diagnostic drug market is poised for exponential growth. Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients and is crucial for myriad of cancer and other therapies. Riding on the back of economic burden of global healthcare and with abundant potential to restrict the liability, companion diagnostic market size is estimated to be $2,950 million as of 2018.

Inquiry Before Buying

Companion Diagnostic Market Outlook:

Companion diagnostic (CDx) is a diagnostic test used as an associate to a therapeutic drug to regulate its applicability to an individual person. It involves multiple monitoring methods including immunohistochemistry (IHC), polymerase chain Reaction (PCR), in-situ hybridization (ISH), real-time PCR (RT-PCR), and gene sequencing. The companion diagnostics uses technologies such as molecular biology technique, drug and diagnostic technology, and oncology therapy for the treatment of colorectal cancer, breast cancer, and other chronic diseases.

 An acute analysis of the region-wise companion diagnostic market share concluded with reckoning North America as the most lucrative market for CDx. This region with cutting-edge healthcare technology in the United States and Canada generates 41% of the global companion diagnostic market demand for alarming need for cancer diagnosis and treatment. According to the American Cancer Society, prostate cancer is the most common cancer among males (19%), followed by lung (14%) and colorectal (9%) cancers and among females, breast (30%), lung (12%), and colorectal (8%) cancers are the most common. Increasing instances of cancer along with neurological disorders, infectious diseases, Hepatitis A is augmenting the North American companion diagnostic market.

Companion diagnostic market with abundant potential as an effective tool for personalized medicine has found a tremendous scope of application in pharmaceuticals, laboratories, research institutes and hospitals. Hospital as an end-user industry is the leading segment progressing with an application CAGR of 12.5% going through 2025. Hospitalized patients account for a total of 2.74 million serious adverse drug reactions. Each CDx test is specifically designed to be corresponding with an exact drug. Such tests can also save significant hospital expenditure by targeting specific patients with the most effective therapy.

Request Sample

 Companion Diagnostic Market Trends and Growth Drivers:

·         The necessity for personalized therapeutics for the cumulative geriatrics population and the increasing figure of diagnostics centers in both the developed and developing economies is predominant to determine profits in the global companion diagnostics market.

·         FDA had issued "Guidance for Industry: In Vitro Companion Diagnostic Devices," to assist syndicates recognize the necessity for companion diagnostics at an initial stage in the drug development procedure and to strategize for co-development of the drug and companion diagnostic test.

 On July 15, 2016, FDA introduced the draft regulation, "Principles for Co-development of an In Vitro Companion Diagnostic Device with a Therapeutic Product." This guidance text is envisioned to be a practical guide to support therapeutic product promoters and IVD sponsors in evolving a therapeutic product and an associated IVD companion diagnostic. The scientific progressions in the in-situ hybridization and automated silver-enhanced in-situ hybridization (SISH) for the monitoring of genes is trending in the global companion diagnostics market.

Schedule a Call

 Companion Diagnostic Market Players Perspective:

Some of the key players influencing the global market are:-  Abbott Laboratories, Agilent Technologies, biomerieux, Bio-Genex Laboratories, Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., QIAGEN N.V., R-Biopharm AG, and Roche Diagnostics.

In April 2017, Abbott acquired Alere for a new price of about $5.3 billion. Alere is the global leader in point of care diagnostics focused on the areas of infectious disease, molecular, cardiometabolic and toxicology. The collective business will offer the biggest point of care menu of infectious disease, molecular, cardiometabolic and toxicology testing. Abbott's platforms will be expanded to comprise benchtop and rapid strip tests.

Buy Now

 Companion Diagnostic Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the companion diagnostic market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various diagnostics in companion diagnostic market, and their specific advantages.

[skyquesttinsights]

Polymerase Chain Reaction Market Surge: Future of Genetic Testing and Diagnostics

The Polymerase Chain Reaction (PCR) market is experiencing significant growth, driven by advancements in technology and increasing demand across various sectors. According to a recent report by SkyQuest Technology, the global PCR market is poised for substantial expansion, reflecting its crucial role in medical diagnostics, research, and biotechnology.

PCR, a technique developed in the 1980s, has revolutionized the field of molecular biology by allowing scientists to amplify specific DNA sequences. This process is essential for various applications, including disease diagnosis, genetic research, and forensic analysis. The report highlights that the PCR market has been growing steadily, with expectations of continued expansion in the coming years. The Polymerase Chain Reaction (PCR) Market size was valued at USD 24.17 billion in 2022 and is poised to grow from USD 24.75 billion in 2023 to USD 29.92 billion by 2031, growing at a CAGR of 2.4% during the forecast period (2024-2031).

Get Your Free Sample Report Here - https://www.skyquestt.com/sample-request/polymerase-chain-reaction-market

Key Drivers of Growth

Several factors are contributing to the growth of the PCR market:

1. Technological Advancements: Innovations such as real-time PCR and digital PCR are enhancing the accuracy and efficiency of genetic testing. These advancements are broadening the scope of PCR applications, from personalized medicine to infectious disease detection.

2. Increased Demand in Diagnostics: The global health crisis underscored the importance of rapid and reliable diagnostic tools. PCR has become a cornerstone in the detection of pathogens, including the SARS-CoV-2 virus, which has led to a surge in demand for PCR-based testing.

3. Expansion of Research and Development: The rise in research activities in genomics and proteomics is driving the need for advanced PCR technologies. Academic and research institutions are investing in PCR systems to support their studies and innovations.

4. Growing Biotechnology Sector: The biotech industry’s expansion is another significant driver. Companies are increasingly adopting PCR for drug discovery, development, and quality control, further propelling market growth.

Top Player’s Company Profile - Thermo Fisher Scientific, Inc., Roche Holdings AG, Bio-Rad Laboratories, Inc., QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Danaher Corporation, Promega Corporation, Merck KGaA, Fluidigm Corporation, Eppendorf AG, Takara Bio Inc., Abbott Laboratories, BioMérieux SA, PerkinElmer, Inc., BioFire Diagnostics, LLC, Biosearch Technologies, Inc., GenMark Diagnostics, Inc., Enzo Biochem, Inc., Illumina, Inc., New England Biolabs, Inc., Quantabio, LGC Limited, Bioer Technology Co., Ltd

Market Segmentation

The report provides a detailed analysis of the PCR market, segmented by product type, application, and region:

- Product Type: The market is categorized into instruments, reagents, and software. Instruments, including PCR machines and thermal cyclers, are the largest segment due to their essential role in the PCR process.

- Application: PCR is utilized in various fields such as clinical diagnostics, research, and forensic applications. Clinical diagnostics, particularly in infectious disease detection, holds the largest market share.

- Region: North America leads the market due to the presence of advanced healthcare infrastructure and high research funding. However, the Asia-Pacific region is expected to witness the fastest growth, driven by increasing healthcare investments and rising awareness.

Want to customize this report? Get Your Free Customize Report - https://www.skyquestt.com/speak-with-analyst/polymerase-chain-reaction-market

Recent Developments

In February 2023: Qiagen announced the release of its new QIAsymphony Dx Real-Time PCR System, that is designed to be greater person-pleasant and efficient than preceding PCR systems.

In March 2023: Roche Diagnostics launched its new cobas SARS-CoV-2 PCR check, which is a fast and accurate test for the detection of COVID-19.

In April 2023: Illumina announced the release of its new MiSeq 5Dx sequencing system, which is able to sequence up to 300 genomes consistent with day.

In May 2023: Thermo Fisher Scientific launched its new Applied Biosystems TaqMan Profiler Plus SARS-CoV-2 Assay, that's a quantitative PCR assay for the detection of SARS-CoV-2.

In June 2023: Agilent Technologies announced the release of its new 2100 Bioanalyzer System, which is a high-throughput DNA evaluation system. The PCR market is set for robust growth, underpinned by technological advancements and increasing demand across various applications. As the technology continues to evolve, it promises to deliver more precise and efficient solutions, further solidifying its role in medical diagnostics and research. For stakeholders in the PCR market, staying abreast of technological developments and market trends will be crucial in navigating the evolving landscape and leveraging opportunities for growth.

[heathcareforallworld]

Trends and Projections for the Taq DNA Polymerase Market

The Taq DNA Polymerase Market is witnessing significant growth due to the increasing demand for polymerase chain reaction (PCR) technologies in various fields such as medical diagnostics, biotechnology, and forensic science. As the backbone of PCR, Taq DNA polymerase is indispensable for amplifying DNA sequences, making it a crucial component in research and clinical laboratories worldwide. This article delves into the market size, share, industry trends, and forecasts for the Taq DNA polymerase market through 2032.

Market Overview

Taq DNA polymerase is a thermostable enzyme extracted from the bacterium Thermus aquaticus, which is capable of withstanding high temperatures required for PCR. This enzyme's ability to replicate DNA sequences efficiently and accurately under thermal cycling conditions has revolutionized molecular biology and genetic research.

Market Size and Share

Taq dna polymerase Market Size was estimated at 1.6 (USD Billion) in 2023. The Taq Dna Polymerase Market Industry is expected to grow from 1.69(USD Billion) in 2024 to 2.53 (USD Billion) by 2032. The taq dna polymerase Market CAGR (growth rate) is expected to be around 5.19% during the forecast period (2024 - 2032).

North America currently holds the largest market share, accounting for over 40% of the global market. This dominance is attributed to the region's well-established biotechnology and pharmaceutical industries, extensive research activities, and the presence of key market players. Europe follows closely, with significant contributions from countries like Germany, the UK, and France. The Asia-Pacific region is expected to witness the fastest growth, driven by increasing investments in biotechnology, rising healthcare expenditure, and growing awareness about molecular diagnostics.

Industry Trends

Technological Advancements: The Taq DNA polymerase market is benefiting from continuous technological innovations. The development of high-fidelity and fast-cycling Taq polymerases has enhanced the efficiency and accuracy of PCR, expanding its applications in various fields.

Rising Demand for Molecular Diagnostics: The increasing prevalence of infectious diseases, genetic disorders, and cancer has fueled the demand for molecular diagnostics. Taq DNA polymerase plays a crucial role in diagnostic assays, including COVID-19 testing, driving market growth.

Expansion of Personalized Medicine: The shift towards personalized medicine, which relies on genetic profiling for tailored treatments, is boosting the demand for Taq DNA polymerase. PCR-based techniques are integral to genetic testing and the development of personalized therapies.

Growing Research and Development Activities: The surge in research and development activities in genomics, proteomics, and biotechnology is propelling the demand for Taq DNA polymerase. Government and private sector investments in research are further stimulating market growth.

Increased Forensic Applications: The application of PCR in forensic science for DNA profiling and criminal investigations is expanding. Taq DNA polymerase is a vital tool in forensic labs, aiding in the accurate identification of individuals from biological samples.

Market Drivers

Advancements in PCR Technology: Innovations such as real-time PCR (qPCR) and digital PCR (dPCR) are driving the adoption of Taq DNA polymerase. These advanced techniques offer higher sensitivity, specificity, and quantification capabilities, broadening the scope of PCR applications.

Growing Biotechnology Industry: The biotechnology industry's rapid growth, coupled with increasing investments in genetic research, is boosting the demand for Taq DNA polymerase. The enzyme is essential for various applications, including cloning, sequencing, and gene expression analysis.

Increasing Prevalence of Genetic Disorders: The rising incidence of genetic disorders and the need for early diagnosis and treatment are driving the demand for PCR-based diagnostic tests. Taq DNA polymerase is a key component in these tests, contributing to market growth.

COVID-19 Pandemic: The COVID-19 pandemic has significantly increased the demand for PCR testing, highlighting the importance of Taq DNA polymerase. The enzyme's critical role in detecting the virus has led to a surge in production and sales.

Challenges

High Cost of Enzyme Production: The production of high-quality Taq DNA polymerase involves complex processes and significant investment, leading to high costs. This can be a barrier for small-scale laboratories and research institutions.

Competition from Alternative Enzymes: The market faces competition from alternative DNA polymerases with improved properties, such as higher fidelity and faster cycling times. The development and adoption of these alternatives can impact the market share of Taq DNA polymerase.

Stringent Regulatory Requirements: The stringent regulatory requirements for the approval and commercialization of diagnostic and research products can pose challenges for market players. Compliance with these regulations can be time-consuming and costly.

Market Forecast (2024-2032)

The Taq DNA polymerase market is poised for substantial growth over the forecast period. Key factors contributing to this growth include:

Expanding Applications in Diagnostics and Research: The ongoing advancements in PCR technology and the expanding applications in diagnostics and research are expected to drive market growth. The enzyme's versatility and reliability make it indispensable in various fields.

Increasing Investments in Biotechnology: The increasing investments in biotechnology and genetic research by governments, private companies, and research institutions will propel the demand for Taq DNA polymerase. The enzyme's role in groundbreaking research and development activities will continue to drive market expansion.

Emerging Markets in Asia-Pacific: The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare expenditure, increasing biotechnology investments, and growing awareness about molecular diagnostics. Countries like China, India, and Japan are key markets to watch.

Adoption of Personalized Medicine: The shift towards personalized medicine and the growing demand for genetic testing will boost the market for Taq DNA polymerase. The enzyme's critical role in genetic analysis and the development of personalized therapies will drive its adoption.

Conclusion

The Taq DNA polymerase market is on a robust growth trajectory, driven by technological advancements, increasing demand for molecular diagnostics, and expanding research and development activities. Key players in the industry are focusing on product development, strategic collaborations, and expanding their geographical presence to capitalize on the growing demand for Taq DNA polymerase.

[wellnessweb]

Analyzing the Blood Transfusion Diagnostics Market Size Growth

The Blood Transfusion Diagnostics Market was estimated at USD 4.70 billion in 2022 and is poised to reach 8.38 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 7.2% for the forecast period of 2023-2030.The Blood Transfusion Diagnostics Market is experiencing significant growth driven by advancements in medical technology and the increasing prevalence of chronic diseases that necessitate frequent blood transfusions. This market encompasses a range of products and services, including blood grouping and typing reagents, infectious disease screening tests, and advanced molecular diagnostic tools. The demand is particularly high in regions with robust healthcare infrastructure and rising awareness about blood safety. Innovations in automation and point-of-care testing are enhancing the efficiency and accuracy of diagnostics, leading to better patient outcomes. Additionally, stringent regulatory standards and initiatives promoting voluntary blood donation are propelling the market forward, ensuring a reliable supply of safe blood for transfusions.

Get Sample of This Report @ https://www.snsinsider.com/sample-request/2968

Market Scope & Overview

The market research report may aid readers in understanding the company's challenges and opportunities. The most recent data on technological advancements and consumer development potential based on location are provided by the global market study. The global Blood Transfusion Diagnostics  Market research report dives into crucial market data, including market size, prospective industry growth, and organisational structure. This study also offers a fresh perspective on the global demand for many of the studied categories as well as an in-depth analysis of a technical investment through time.

The analysis of novel products, R&D initiatives, and new technologies in-depth is all a part of Blood Transfusion Diagnostics  Market research. The report looks at all of the important advancements and discoveries that are anticipated to have a big impact on the growth of the global market in the next years. Similar to that, the study evaluates every industry in various countries and offers a cross-sectional analysis of estimates of worldwide demand.

Market Segmentation Analysis

By Product

Consumables

Instruments

Services

By Technique

PCR-based and Microarray Techniques

Assay-based Techniques

Massively Parallel Sequencing Techniques

Other Techniques

By Test Type

Antibody Screening

HLA Typing

Cross-matching Tests

ABO Blood Tests

Antigen Typing

Russia-Ukraine Conflict Impact Analysis

In the midst of the Russia-Ukraine crisis, the market research report on Blood Transfusion Diagnostics  Market examines a variety of market factors, challenges, and opportunities that will probably affect market growth.

Regional Outlook

By presenting a comprehensive competitive environment as well as a commodities supply of the primary providers dispersed across several geographical regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, the Blood Transfusion Diagnostics  Market research report gave readers a realistic view of the industry.

Competitive Analysis

The research report includes the most recent market forecast analysis for the anticipated time. In addition to real information and dates, each part of the research report includes an overview and synopsis. The research report offers a thorough analysis of industry competition as well as a summary of Porter's Five Forces model to help readers understand the competitive environment faced by the major international suppliers to the Blood Transfusion Diagnostics  Market.

Key Reasons to Purchase Blood Transfusion Diagnostics  Market Market Report

Supply chain analysis, top-level firm market share analysis, business analysis (industry trends), and succinct sector profiles are just a few of the layers that the research delves extensively into.

The best approach to learn about a market and the most recent advancements is through market research surveys, which will help you make smarter business decisions.

Conclusion

Readers will get all the key details needed to fully comprehend your target industry in the Blood Transfusion Diagnostics  Market research report. Important business environment concepts, high-growth markets, high-growth nations, notable industry variations, business variables, and constraints are also covered in this research report.

Read Full Report @ https://www.snsinsider.com/reports/blood-transfusion-diagnostics-market-2968

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Forensic Technology Industry

Functional Service Providers Industry

Genome Editing Industry

Genomics Services Industry

Health IT Security Industry

[globalaircraftgalley]

Global Companion Diagnostics Market Scope and Challenges

Global Companion Diagnostics Market will exhibit a growth rate of 13.85% for the forecast period of 2021-2028

Global Companion Diagnostics Market Analysis and Insights:

A companion diagnostic refers to a medical device that is utilized as in- vitro device that provides information about safety and effectiveness of drug. This is a kind of test that can assist a healthcare professional in determining the beneficial effect of therapeutic products. It also helps in analyzing the serious side effects and risks.

The rise in number of application areas of companion diagnostics across the globe acts as one of the major factors driving the growth of companion diagnostics market. The rise in adoption rate of these assays by pharmaceutical manufacturers owning to their ability to reduce clinical trial timelines, and increase in need for targeted therapy accelerate the market growth. The increase in popularity of companion diagnostic because of economic benefits offered by oncology Companion Diagnostics (CDx) assays, and rise in the prevalence of cancer further influence the market. Additionally, rise in population, growing importance of personalized medicine and surge in healthcare expenditure positively affects the companion diagnostics market. Furthermore, increase in demand for next-generation sequencing and rise in number of clinical trials extend profitable opportunity to the market players in the forecast period of 2021 to 2028.

On the other hand, high cost associated with the companion diagnostic tests and uncertain reimbursement scenario in different regions are expected to obstruct the market growth. Shortage of trained professionals is projected to challenge the companion diagnostics market in the forecast period of 2021-2028.

 This companion diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on companion diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Get full Report: https://www.databridgemarketresearch.com/reports/global-companion-diagnostics-market

Global Companion Diagnostics Market Scope and Market Size:

On the basis of product and services, the companion diagnostics market is segmented into assay kits and reagents, and software & services.

On the basis of technology, the companion diagnostics market is segmented into polymerase chain reaction, molecular diagnostics, FISH, CISH, immunohistochemistry, real-time PCR, next-generation sequencing, gene sequencing, and in situ hybridization.

On the basis of indication, the companion diagnostics market is segmented into oncology, neurology and infectious diseases. Oncology is further segmented into breast cancer, lung cancer, colorectal cancer, gastric cancer, and melanoma.

 Global Companion Diagnostics Market Country Level Analysis:

The countries covered in the companion diagnostics report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Competitive Landscape & Companion Diagnostics Market Share Analysis:

Companion diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of companion diagnostics market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Get sample report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-companion-diagnostics-market

 Major Players:

F. Hoffmann-La Roche Ltd.,

Qiagen,

Abbott,

Almac Group,

Agilent Technologies, Inc.,

Clinical Lab Products,

Myriad Genetics, Inc.,

Leica Biosystems Nussloch GmbH,

Resonance Health,

Major TOC of the Report:

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview  

Chapter Four: Executive Summary

Chapter Five: Premium Insight

Chapter Six: COVID-19 Impact on Global Companion diagnostics Market

 Get TOC here: https://www.databridgemarketresearch.com/toc/?dbmr=global-companion-diagnostics-market

 About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

 Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[soumyafwr]

PCR and Real-time PCR Molecular Diagnostics Market Size, Analysis and Forecast 2031

[marketreports-world]

Global Malaria Diagnostics Market - Forecast Till 2027

Malaria Diagnostics Market Trends, Growth and Insights by Technique (Rapid Diagnostic Tests, Microscopy and Molecular Diagnostic Tests, and Others) and by End-Users (Hospitals, Clinics, and Others) – Global Forecast Till 2027

Market Highlights

Primary and precise diagnosis of malaria is essential for both fast and effective disease management and observation. Superior quality malaria diagnosis systems are important in all settings as misdiagnosis or misinterpretation can result in substantial morbidity and mortality. World Health Organization (WHO) recommends a quick malaria diagnosis either by microscopy or malaria rapid diagnostic test (RDT) in all patients with suspected malaria before treatment is being administered. Diagnostic testing improves the overall management of patients with febrile illnesses and may also help to decrease the emergence and spread of drug resistance by storing antimalarials for those who have the disease. The scope of malaria diagnostics is growing rapidly with technological advancements and a growing number of investments. Also, growth in a number of hospitals and healthcare facilities, and initiatives taken by the government are the major factors driving the growth of the malaria diagnostics market. The malaria diagnostics market is expected to grow at 4.6% CAGR during the forecast period

However, the dearth of appropriate monitoring standards at the country levels particularly in developing markets hinders the growth of the market. The weak regulatory framework and lack of awareness across the emerging nations is also a prime concern for the manufacturers and healthcare providers.

Segmentation

The global malaria diagnostics market has been segmented on the basis of technology and end-user.

On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR). On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.

Regional Analysis

The Americas is projected to lead the malaria diagnostics market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market.  

The European market is expected to hold the second largest market share. The European market is projected to grow because of the malaria cases brought in the European region by tourists and refugees. The European Centre for Disease Prevention and Control, stats reported a range of 5000 -7000 cases of malaria from 2008 to 2012.

Asia-Pacific is projected to be the fastest growing region for the global malaria diagnostics market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. The diagnostic testing market, by volume, in India is controlled by microscopy testing. With increasing awareness and growing funding from care-based surveillance systems, private sectors and national governments the necessity for diagnostic testing procedures are projected to rise, thereby boosting the market development.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income. Southeast Asia accounted for about 10% of the global cases, however, the death rate was around 7% in the same year.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6432

Key Players

Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/malaria-diagnostics-market-6432

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Related Report:

Global Knee replacement Market Research Report- Forecast To 2027

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

[decisionforsight]

Global Covid 19 Nucleic Acid Testing Kits Market

Global Covid 19 Nucleic Acid Testing Kits Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

The global covid-19 nucleic acid testing kits market size is estimated to reach XXX USD by 2030 at a CAGR of XXX during the forecast period. Nucleic acid testing is generally used in the treatment of infectious diseases caused by bacteria and viruses, cancerous diseases, as well as genetically related diseases. It provides an extra layer of blood screening and overcomes incorrect reactive definitions, and also aids in detecting the issue without any prior signs. Nuclear acid testing is also an early detection technique which is proven to provide reliable diagnosis, quicker than any other available method, which helps to narrow down infectious times, i.e. the window duration between the time of viral transmission and the time of serological detection of a virus. Due to this, it is regarded as one of the most desired research procedures of the healthcare industry.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020243

Market Dynamics and Factors : 

The major factors driving the covid-19 nucleic acid testing kits market across the globe are the technological advancements in the overall healthcare industry, increasing R&D in the field of pharmaceuticals and healthcare. The requirement for highly equipped kits in several diagnostic areas such as cancer, infectious diseases, paternity testing and forensic testing are majorly attributing to the growth of the covid-19 nucleic acid testing kits market. Growing demand for technologically advanced sample processing, extraction, amplification and testing methods for nucleic acids such as DNA and RNA, and  strategic agreements of manufacturers’ with leading research institutes are expected to boost research activities in the area of molecular biology. There is also an increased scope of the global application of nucleic acid testing, as manufacturers of molecular diagnostic instruments and kits have produced many products with the potential to be used in research as well as clinical diagnostics. However, certain factors like adverse events and false operational functionality associated with the reagents are hampering the covid-19 nucleic acid testing kits market growth during the forecast period. Lockdown in several countries as well as pause in business operations due to COVID 19 is also a major factor hampering the market.

Market Segmentation :

Global Covid 19 Nucleic Acid Testing Kits Market - By Type:

Fluorescent PCR

Thermostatic Amplification Chip

Global Covid 19 Nucleic Acid Testing Kits Market - By Application:

Hospitals

Scientific Research

Diagnostic Center

Global Covid 19 Nucleic Acid Testing Kits Market - By Region:

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Rest of Europe

Asia Pacific

China

India

Japan

Australia

Rest of APAC

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020243

Geographical Analysis :

North America is expected to dominate the global covid-19 nucleic acid testing kits market in terms of market share during the forecast period followed by Europe. This is because of the well-established healthcare system and several established pharmaceutical companies in the region.Latin America and Middle East & Africa are expected to witness sluggish growth during the forecast period. The improper development and implementation of clinical practice guidelines and dearth of skilled professionals in most of the countries in the region will possibly continue to hinder the growth of the covid-19 nucleic acid testing kits market.

Competitive Scenario :

The key players operating in the global covid-19 nucleic acid testing kits industry include Shanghai Geneodx Biotech, Shanghai ZJ Bio-Tech, Zhongshan Daan Gene, Genomics Biotech (Wuhan), Shanghai Bio-Germ, Sanaure, Beijing XABT, Chengdu Boaojing Bio-Tech, Wuhan Easydiagnosis Biomedicine and Maccura Bio-Tech.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020243 

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Covid 19 Nucleic Acid Testing Kits industry, although key threats, opportunities and disruptive technologies that could shape the Global Covid 19 Nucleic Acid Testing Kits Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Covid 19 Nucleic Acid Testing Kits Market most.

The data analysis present in the Global Covid 19 Nucleic Acid Testing Kits Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Covid 19 Nucleic Acid Testing Kits Market business.

The 2021 Annual Global Covid 19 Nucleic Acid Testing Kits Market offers:

100+ charts exploring and analysing the Global Covid 19 Nucleic Acid Testing Kits Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Covid 19 Nucleic Acid Testing Kits Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020243 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[esglatestmarketnews]

Gene Expression Analysis Market Segments, Growth and Forecast Analysis Report till 2025

June 23, 2021: The global gene expression analysis market is estimated to reach USD 11.3 billion by 2025. Market is also expected to grow at a decent rate over the forecast period driven by rising number of cancer patients, facilities for financial funding, decreased cost of sequencing, and high concentration on research & development. In emerging economies, the industry offers advantageous opportunities for growth with rising concentration on adoption and precision as well as personalization in medicines. However, currency devaluation in developing economies and initial capital investment of different instruments are considered as restraint as well as challenge for the industry.

The gene expression is a set of steps for a functional genetic code product occur in the synthesis, with the support of the data coded on genes. The process is prominent in multi cellular organisms as well as bacteria such as eukaryotes or prokaryotes, which ensure the creation of machinery macro molecular of their life.

In context with the consumables of gene expressions, the industry is classified into DNA chips and reagents. The segment of reagent held the largest revenue share of consumables in the industry. This segment is anticipated to witness high growth influenced by increasing number of service center for sequencing, research & development with financial funding, and rising installation number of analysis instruments.

The overall market can be segmented by technologies into Northern Blotting, SAGE, Micro array, DNA, NGS, and PCR. The NGS technological segment is considered to be the rapidly growing sector. However, the PCR technology held the largest revenue share over the forecast period. The rapid growth of NGS technology is influenced by rise in large scale gene expression demand, technological advancement & improvised throughput & speed, wide spectrum of applications, and in depth knowledge of sequencing DNA.

Request a Free Sample Copy of this Report @ https://www.millioninsights.com/industry-reports/gene-expression-analysis-market/request-sample

The services offered by this industry are classified as bio informatics solutions and profiling services. Profiling services of gene expressions occupy the largest industry share. The profiling services provide essential insights in terms of personalized medicine, determining drug, and enhanced diagnosis of disease. Aforementioned factor would drive the demand for profiling services over the forecast period.

The genetic code expression includes translation and transcription process. The translation process protein from RNA is a sequence occurs in the protein-based synthesis on coding genes data. The transcription from DNA to RNA can be described to the creation of coples RNA of DNA with the support of the RNA enzyme polymerase. The regulations of genetic code refer to its functions, renders cell control through structure, versatility & differentiation of cellular substance, and morphogenesis. The alteration in the overall process can be possible with such as modification of proteins after translation process, and splicing of RNA.

The profiling primarily refers to the set of step used to measure the expression of numerous genetic codes in order to determine the functions related to cellular. This process can be helpful to determine the differences in molecular base of phenotypic and offers the target GE selection for research purpose. There are various techniques used for this analysis such as transcriptase sequencing, analysis of micro array, PCR based real time profiling, and serial analysis of GE among others.

However, reagents are the chemical substances required in the studies undertaken to identify the pattern. Traditionally available reagents kits include hybridization, Taq Man assay, sample labeling and amplification, sample preparation and isolation and other significant kits.

The North America industry is estimated to hold the largest share, followed by Asia Pacific and Europe. The Asia Pacific region is estimated for the rapid growth over the forecast period. The growth in this region is influenced by increasing gene test popularity, government concern to improve healthcare with laws & regulation, and rising agriculture research activity.

The vital factors influencing the growth and contribution of aforementioned region include development of databases, increasing R & D, and continuous advancement & innovation in technology across the world. Rising initial funding and investment for research in genetic by government as well as the growing awareness & popularity of gene expressions is expected to shift demand. Recently, classified systems of GE have determined a cancer subtype aggressive colon with features like mesenchymal, which ensures EMT of tumor cells.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/gene-expression-analysis-market

Some of the major players competing in this industry are Agllent Technologies, Bio Rad Laboratories, Thermo Fisher Scientific, Qiagen N.V., Illunia Inc., Affymetrix Inc., and other prominent players. High initial cost for instruments as well as lack of expertise & skilled technician would hinder the growth. However, with numerous advantages and rising interest for precise medicines, the growth & scope of new studies would influence the adoption of reagents.

Market Segmentation

Process Outlook (Revenue, USD Million; 2014 - 2025)

• Sample Collection

• Purification

• cDNA synthesis & conversion

• PCR Analysis

• Data analysis & interpretation

Product Outlook (Revenue, USD Million; 2014 - 2025)

• Kits & Reagents

• DNA Chips

• Others

Capacity Outlook (Revenue, USD Million; 2014 - 2025)

• Low- to Mid- Plex

• High-Plex

Technique Category Outlook (Revenue, USD Million; 2014 - 2025)

• RNA Expression

• Northern Blotting

• DNA Microarrays

• PCR Techniques

• RNA-Seq

• Promoter Analysis

• In vitro Transcription/Nuclear Run-On Assays

• Gel Shift Assays

• Chromatin Immunoprecipitation (ChIP)

• Protein Expression & Posttranslational Modification Analysis

• Western Blotting

• 2-D Gel Electrophoresis

• Immunoassays

• Mass Spectrometry

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Drug Discovery & Development

• Clinical Diagnostics

• Biotechnology & Microbiology

• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America

• U.S.

• Canada

• Europe

• Germany

• UK

• Asia Pacific

• Japan

• China

• Latin America

• Brazil

• Middle East and Africa (MEA)

• South Africa

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

[myoliver123stuff]

Cancer Profiling and Pathways Market on an Upswing due to Autonomous Mobility, Trends Market Research

Global Cancer Profiling and Pathways Market: Overview

Cancer cells usually demonstrate a pattern of modified metabolism creating an environment within the body conducive to the growth of malignant cells and tumors. Knowledge regarding the biochemical characters of cancer facilitates the implementation of various cancer profiling platforms.

Developments in the existing technology are therefore essential to support deciphering the scope of altered metabolism of cancer cells. Novel technologies are high in demand as they can help identifying cellular structures and modified enzymes in cancer. Widely used cancer profiling methods such as metabolomics, proteomics, and genomics explicate the metabolic pathways favoring metastasis and tumorigenesis. These endeavors in cancer profiling have facilitates not only understanding regarding the fundamental biochemistry of cancer, but have facilitated the discovery of modalities promoting efficient cancer therapy.

The report provides a comprehensive overview of the global cancer profiling and pathways market. Besides providing a detailed assessment of the growth drivers and restraints influencing the market between 2020 and 2028, the report also gauges the impact of the latest innovations in the market. The effect of government policies is studied as well. Using Porter’s five forces the report assesses the bargaining power of suppliers and buyers, the degree of competition, and threat from new entrants and product substitute.

Get An Exclusive Sample Of the Research Report at: https://www.trendsmarketresearch.com/report/sample/13500

The report thus analyzes in detail factors fuelling the competition in the global cancer profiling and pathways market. It also presents insights into the diagnostics and therapeutics, newly emerging tools, and other similar factors that are likely to influence the market’s trajectory over the course of the forecast period. It is therefore compiled with exhaustive information aimed at providing readers an in-depth perspective of prevailing dynamics in the global cancer profiling and pathways market.  It also identifies the growth opportunities that lay ahead for the market participants.

Global Cancer Profiling and Pathways Market: Trends and Opportunities

The global cancer profiling and pathways market is driven by the increasing demand for novel biomarkers useful in drug discovery. Meanwhile, the biomarker market derives growth from the demand from the rising aging population, especially across emerging economies in Asia Pacific. The rising incidence of cancer worldwide is also expected to fuel the demand from the market. According to the WHO, 30% of deaths occurring from cancer can be prevented by modifying key risk factors, early detection, and accurate diagnosis. Since cancer profiling technologies help in achieving the same, their demand is projected to rise exponentially over the course of the forecast period.

The cancer profiling technologies currently available in the market are epigenomic profiling, genomic profiling, glycomics, proteomics, transcriptomic profiling, and metabolomics. TMR forecasts an impressive CAGR for the global cancer profiling and pathways market. According to the study, the proteomics segment is expected to hold a substantial share in the market and exhibit healthy growth through the course of the forecast period. Besides this, the growth exhibited by the genomics segment is also expected to remain robust.

Buy Now report with Analysis of COVID-19 at: https://www.trendsmarketresearch.com/checkout/13500/Single

The evolution in technologies such as quantitative real-time PCR, microarray analysis, and multiplex PCR has facilitated in efficiently decoding the molecular mechanisms in cancer. These methods are likely to help in the discovery of new drugs and diagnostic biomarkers. The innovation of novel therapeutics and diagnostic technologies is expected to help the global cancer profiling and pathways market to grow at a robust pace.

Global Cancer Profiling and Pathways Market: Regional Outlook

Regionally, the global cancer profiling and pathways market can be segmented into North America, Europe, Asia Pacific, and Rest of the World. The market is expected to witness significant opportunities in developed regions such as Europe and North America as these regions boast sophisticated healthcare infrastructure. In developing regions as well, the cancer profiling and pathways market will gain from the rising investment in the healthcare industry.

Request For Report Reductions at: https://www.trendsmarketresearch.com/report/discount/13500

Global Cancer Profiling and Pathways Market: Vendor Landscape

To study the vendor landscape of the market, the report profiles companies such as Applied Biosystems, Life Technologies, and Affymetrix. Using SWOT analysis, it gauges their strengths and weaknesses. The analysis also provides insights into the threats and opportunities that the market may face during the forecast period. The strategies adopted by the companies profiled and the impact of the same on the overall market are analyzed in detail.

[leonfrancisblog]

Asia-Pacific HLA Typing Transplant Diagnostics Services Market Industry Analysis Size, Share, Trends and Profitable Segments Breakdown and Detailed Analysis of Current and Future Industry Figures till 2027|Key Players Takara Bio, Fujirebio, Inc., TBG Diagnostics Ltd., Proimmune Ltd., Creative Biolabs, Histogenetics LLC, Admera Health

HLA typing transplant diagnostics services market is expected to reach USD 256.36 billion by 2027 witnessing market growth at a rate of 9.8% in the forecast period of 2020 to 2027. Data Bridge Market Research report on HLA typing transplant diagnostics services market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market’s growth. LA stands for human leukocyte antigen and HLA testing is done to check the compatibility of the donor’s bone marrow or blood with that of the patient receiving it. These HLA are found on our cells and our immune system uses them as markers to identify if there is any foreign cell in our body. For transplant, there needs to be a close match between the donor and the patient as it significantly reduces the risk which can rise, post transplantation.

Various technological advancements in HLA typing, growing number of organ and stem cell transplantation processes, rise in research funding and public private partnerships are the factors driving the growth of HLA typing transplant diagnostics services market. High cost of PCR and NGS equipment, inadequate medical reimbursement for transplantation process and a huge gap between organ donating and transplanting are the restraints for HLA typing transplant diagnostics services market in the above mentioned period. Rising preference for serological analysis to genome based HLA analysis and growing penetration of diagnostics equipment development are the opportunities for HLA typing transplant diagnostics services market. Possibility of mismatch between donor and receiver due to high sequence variability and low public awareness about organ transplantation are the challenges for HLA typing transplant diagnostics services market.

Asia-Pacific HLA Typing Transplant Diagnostics Services Market, By Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), Product & Service (Reagents & Consumables, Instruments, Software & Services), Application (Diagnostic, Research), End User (Independent Reference Laboratories, Hospitals & Transplant Centres and Research Laboratories & Academic Institutes), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2027. This HLA typing transplant diagnostics services market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on HLA typing transplant diagnostics services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. The HLA typing transplant diagnostics services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to HLA typing transplant diagnostics services market.

Get More Info Sample Request on Asia-Pacific HLA Typing Transplant Diagnostics Services Market, @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-hla-typing-transplant-diagnostics-services-market  

Asia-Pacific HLA Typing Transplant Diagnostics Services Market Country Level Analysis:

Asia-Pacific HLA typing transplant diagnostics services market is analyzed and market size, volume information is provided by country, technology, product & service, application and end user as referenced above.

The country section of the HLA typing transplant diagnostics services market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. The countries covered in the Asia-Pacific HLA typing transplant diagnostics services market report are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines and rest of Asia-Pacific. China and India will dominate the growth in Asia-Pacific HLA typing transplant diagnostics services market due to increasing population, better healthcare facilities as well as increase in public-private support to develop and research in HLA typing transplantation. These countries have also been seen as medical tourism destination due to the presence of its advanced medical treatments.

Healthcare Infrastructure growth Installed base and New Technology Penetration:

HLA typing transplant diagnostics services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for HLA typing transplant diagnostics services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the HLA typing transplant diagnostics services market. The data is available for historic period 2020-2027.  

HLA Typing Transplant Diagnostics Services Market Scope and Market Size:

The HLA typing transplant diagnostics services market is segmented on the basis of technology, product & service, application and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of technology, the HLA typing transplant diagnostics services market has been segmented as molecular assay technologies and non-molecular assay technologies. Molecular assay technologies can be further segmented into PCR-based molecular assays and sequencing-based molecular assays. PCR-based molecular assays can be further sub-segmented into real-time PCR, sequence-specific primer-PCR, sequence-specific oligonucleotide-PCR and other PCR-based molecular assays. Sequencing-based molecular assays can be further sub-segmented into Sanger sequencing, next-generation sequencing and other sequencing-based molecular assays. On the basis of product & service, the HLA typing transplant diagnostics services market has been segmented into reagents & consumables, instruments and software & services. On the basis of application, the HLA typing transplant diagnostics services market has been segmented into diagnostic and research. Diagnostic can be further segmented into antibody screening, chimerism monitoring and other applications. LA typing transplant diagnostics services market has also been segmented on the basis of end user into independent reference laboratories, hospitals & transplant centres and research laboratories & academic institutes.

The major players covered in the Asia-Pacific HLA typing transplant diagnostics services market report are Takara Bio, Fujirebio, Inc., TBG Diagnostics Ltd., Proimmune Ltd., Creative Biolabs, Histogenetics LLC, Admera Health, Quick Biology, The Sequencing Center and One Lambda among other domestic and global players. Market share data is available for Asia-Pacific (APAC) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Asia-Pacific HLA Typing Transplant Diagnostics Services Market:

Data Bridge Market Research is a leader in consulting and advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include production cost analysis, trade route analysis, price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), import export and grey area results data, literature review, consumer analysis and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Get Table of Content on Request @ https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-hla-typing-transplant-diagnostics-services-market

Reasons for Buying this Asia-Pacific HLA Typing Transplant Diagnostics Services Market Report:

Laser Capture Asia-Pacific HLA Typing Transplant Diagnostics Services Market report aids in understanding the crucial product segments and their perspective.

Initial graphics and exemplified that a SWOT evaluation of large sections supplied from the Laser Capture Asia-Pacific HLA Typing Transplant Diagnostics Services Market industry.

Even the Laser Capture Asia-Pacific HLA Typing Transplant Diagnostics Services Market economy provides pin line evaluation of changing competition dynamics and retains you facing opponents.

This report provides a more rapid standpoint on various driving facets or controlling Medical Robotic System promote advantage.

This worldwide Locomotive report provides a pinpoint test for shifting dynamics that are competitive.

The key questions answered in this report:

What will be the Market Size and Growth Rate in the forecast year?

What is the Key Factors driving Laser Capture Asia-Pacific HLA Typing Transplant Diagnostics Services Market?    

What are the Risks and Challenges in front of the market?

Who are the Key Vendors in Asia-Pacific HLA Typing Transplant Diagnostics Services Market?  

What are the Trending Factors influencing the market shares?

What is the Key Outcomes of Porter’s five forces model

Access Full Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-hla-typing-transplant-diagnostics-services-market    

Browse Related Report:

Human leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market

North America Human leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market

Europe Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[biotechtimes]

BIRAC Invites Project Proposals For COVID-19 Research Consortium

New Post has been published on https://biotechtimes.org/2020/03/23/birac-invites-project-proposals-for-covid-19-research-consortium/

BIRAC Invites Project Proposals For COVID-19 Research Consortium

BIRAC Call For COVID-19 Research Consortium

To support the preparedness, readiness and response for COVID-19, project proposals are being solicited for developing Diagnostics, Vaccines, Novel Therapeutics, Repurposing of Drugs or any other intervention for control of COVID-19 by Industry/Academia/ Industry-Academia participation. COVID-19 Research Consortium.

Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC)

The current outbreak of coronavirus disease (COVID-19) got reported first from Wuhan, China, on 31 December 2019. Coronavirus disease (COVID-19) is an infectious disease caused by a new virus that had not been previously identified in humans. COVID-19 has been declared as a pandemic by WHO due to the alarming levels of spread and severity. Till date, there is no specific medicine to treat or prevent COVID-19.

In response to the outbreak, there is an urgent need to accelerate the development of diagnostics, vaccines, novel therapeutics and repurposing of drugs for this novel coronavirus. In view of the limited current level of knowledge about the new virus, critical research questions need to be answered urgently, and ways have to be found to fund priority research that can contribute to curtail this outbreak and prepare for future outbreaks. Urgent need to develop safe and effective countermeasures that can be available, accessible and suitable for use in populations most in need. Research is an important integral component of the response to be able to identify key knowledge gaps and research priorities, and thereby accelerate the generation of critical scientific information and the most needed medical products to contribute to the control of 2019-nCoV emergency.

A) PROGRAM GOAL

The theme of the current RFP is:

Developing Diagnostics, Vaccines, novel Therapeutics, repurposing of drugs and any other intervention for control of COVID-19 outbreak”. Projects submitted must take into account the criteria for affordability, wide-spread adoption and have a realistic possibility for scale-up. The scope of the RFP is inclusive of and not exhaustive of the following areas:

Diagnostics:

To develop technologies/Assays/components for diagnosis of coronavirus and SARS-CoV-2 including diagnostic methods such as ELISA, Lateral Flow assay, Molecular diagnostics (PCR, Real-Time PCR), Colorimetric tests, Chemiluminescence, Immunoassays, cell culture.

Vaccines:

Vaccine technology platforms, novel vaccine manufacturing technologies, vaccine candidates and enabling disciplines for coronavirus vaccine development.

Type of candidate vaccine can be DNA, RNA, Live Attenuated Virus, Non-Replicating Viral Vector, Protein Subunit, Replicating Viral Vector at any stage of development.

In-licensing technology for optimization, scale-up, and manufacturing.

Novel Therapeutics:

To develop in-vitro assay/animal models and standardize challenge studies.

Screen existing libraries (Biologicals and Chemicals) and identify potential hits for development.

Novel methods of B-cell isolation/ monoclonal antibody development.

Repurposing of Drugs:

Develop prophylaxis clinical studies and prioritize in healthcare workers.

Evaluate existing marketed drugs under a standard protocol in patients of COVID-19.

Any other:

Development of any other intervention/technology related to SARS-CoV-2 outbreak prevention and control.

B) Key requirements for the proposed technologies/ products that will be considered:

a. The developed process should be sustainable from an economic and environmental point of view

b. The technology should be scalable

C) EXCLUSIONS- Examples of areas that will not be considered:

a. Proposals not related to SARS-CoV-2

b. Projects not having product development component

c. The proposed concept not having commercialization potential

d. The grant is not a research fellowship.

D. APPLICATION OPENING

Important dates for RFP:

Publication on – 19 th March 2020

End date on- 30 th March 2020 at 2.00 pm

E. ELIGIBILITY: The proposals can be submitted by:

a. Company (Start-up, Small, Medium or Large) incorporated under the Companies Act, 2013 having a minimum of 51% of the shares of the Company to be held by Indian Citizens (Indian passport holders).

b. Limited liability Partnership (LLP) incorporated under the Limited Liability Partnership Act, 2008 having a minimum half of the persons who have subscribed their names to the LLP document as its Partners should be Indian citizens (NOTE: The applicant Company/LLP should have adequate in-house facility to address the project implementation (which shall be evaluated during the proposal evaluation) or incubated with any of the recognized incubation facility. DSIR certificate is not mandatory).

c. Academia (Public or Private Research Institute, University) having a well-established support system for research. The institute should have been established in India and have NAAC/ UGC/ AICTE or any equivalent recognition certificate or any other Public/Government supported organization

d. Non-academic Individuals (NAI)

The application can be submitted by any of the above entities (a – d) jointly or severally

F. FUNDING MODALITIES

Funding Support for COVID-19 Research: Grant‐in‐aid assistance will depend on the proposed activities.

Duration: Project duration can be up to 24 months (encouraged to develop the solution in 6-12 months wherever possible).

Depending on the scope of activities and the applicant, the funding will be made available under DBT/different schemes of BIRAC/Ind-CEPI/National Biopharma Mission.

G. APPLICATION PROCESS

a. Process of application submission

Proposals in the form of a Letter of Intent are required to be submitted online only. Online proposal submission can be done by registered users. The RFP will be open for a period of 12 days. Process for submitting the proposals online is detailed below:

Log on the BIRAC website (www.birac.nic.in)

Registered users may log-in using the credentials and new users need to register the institution with by clicking on New User Registration.

In case of new user registration, a computer-generated password is sent to the email id provided at the time of registration.

Upon login, the user is navigated to the page displaying the specific scheme link.

Click on the link under Programmes and the active call would be highlighted.

Click on the active call against which the proposal needs to be submitted.

b. Process for selection of the proposals for COVID-19 Research

i. The process of evaluation broadly comprises the following steps:

ii. Eligibility check of mandatory legal parameters

iii. Review of LOI by Scientific Advisory Group (SAG)

iv. Presentation of the applicant of selected proposals to SAG

v. Final recommendations and execution of funding agreement vi. The proposals will be evaluated based on the following criteria:

Scientific Merit

The technical strength of the proposal

Clarity of technical strategy

Innovation level

Level of Risk

Investigator’s Credentials and/or collaborative team’s expertise.

H. SCOPE OF INTELLECTUAL PROPERTY GENERATED DURING THE DURATION OF THE PROJECT

The New Intellectual Property (IP) rights will be as per the policy of the grant scheme.

It is the responsibility of the Fund Recipients to protect the New Intellectual Property (New IP).

NOTE: For the purpose of this GLA, New IP means intellectual property generated during the conduct of the Project by the Fund Recipient(s), but excluding the intellectual property generated by the Fund Recipient(s) before the execution of this GLA and any IP generated outside the scope of this GLA even during the term of this GLA.

I. PROJECT MONITORING & MENTORING

a. Project Monitoring Committee (PMC)

The projects shall be monitored/and mentored regularly by an Expert Committee constituted by BIRAC for each project. Site visits shall be conducted by specially constituted Expert Committees comprising two to three Technical experts and one financial expert. The Project Monitoring Committee (PMC) is responsible for;

i. Monitor the progress of the Project in conformity with the outputs, milestones, targets and objectives is contained in the Agreement.

ii. Based on the foregoing, to assess and recommend:

The release of the next installment or part release thereof by the BIRAC.

revision of project duration

closing or dropping or modifying any of the components of the Project, within the overall approved objectives, budget and time-frame,

the inclusion of additional industrial/institutional partner(s), if the applicant requests involvement of such partner(s), in the overall interest of the Project,

mentor(s) to overcome any technological problem faced in the Project implementation; and

Revision of financial assistance.

iii. To advise on issues related to securing of IPR and

iv. To advise on any other matter as referred to it by BIRAC and/or otherwise reasonably necessary for effective discharge of its duties and/or achievement of aims and objectives of the proposed Scheme.

b. Reporting of Progress on COVID-19 Research

On Successful completion of each Milestone, the applicant will be required to submit a detailed Milestone Completion Report (MCR) as per the prescribed format.

The MCR will be assessed by the PMC for its completion. On the recommendation of the PMC, the next Milestone budget is released.

The Applicant will have to submit a duly certified Statement of Expenditure for the every 30th September and 31st March. 

Format for Milestone Completion Report (MCR), Utilization Certificate and Statement of Expenditure will be made available as per requirement.

J. TERMS & CONDITIONS AND REQUISITES FOR FUND DISBURSEMENT

a. Agreement of funding for COVID-19 Research

On the announcement of Award, all concerned applicants need to sign the Grant-in-aid Letter Agreement (GLA) with BIRAC.

K. OTHER REQUISITES FOR FUNDS DISBURSEMENTS

a. In addition to signing of agreement between all the concerned parties, the following requirement needs to be completed before the first instalment can be released:

A Board Resolution needs to be passed for acceptance of the Grant-in-aid offer by the BIRAC

Opening up a No-Lien Account with a scheduled/nationalized Bank in case of a Company

Letter of Authorization in case of Institute in the prescribed format of BIRAC

MoUs related to IP arrangements/collaborations/outsourcing etc needs to be in place

L. ACKNOWLEDGEMENT OF BIRAC SUPPORT

Acknowledge the assistance of BIRAC while publishing, marketing the resultant Product or presenting in any manner the details of the project, its progress or its success along with the “Disclaimer” that reference therein to any specific commercial product, process, views or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or assuming the liability of any sort by the BIRAC. The use of BIRAC logo is not permitted without written approval.

M. CONTACT INFORMATION

Further information can be obtained at BIRAC Website: www.birac.nic.in

Contact Person Dr. Artee, Manager-Investment: inv03@birac.nic.in

Download Notification

[onkar872019]

Global Veterinary Molecular Diagnostics Market to represent a significant expansion at 8.48% CAGR by 2026

Data Bridge Market Research has recently added a concise research on Global Veterinary Molecular Diagnostics Market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline. Some are the key & emerging players that are part of coverage and have being profiled are Virbac, General Electric Company, Agfa-Gevaert Group., Veterinary Molecular Diagnostics, Inc.,  Novacyt Group, Qiagen , Biomedica Medizinprodukte GmbH & Co KG, Veterinary Laboratory - HealthGene Corp. , Bioneer, Abaxis, Neogen Corporatio.

Analysis of Global Veterinary Molecular Diagnostics Market report:

Global Veterinary Molecular Diagnostics Market is expected to rise from its initial estimated value of USD 453.83 million in 2018 to an estimated value of USD 870.34 million by 2026 registering a CAGR of 8.48% in the forecast period of 2019-2026. Molecular diagnostic market is driven by Increasing incidence of numerous animal diseases and by increasing expenditure on pet animal.

Definition:

The molecular diagnostic is a laboratory method for examining the RNA or DNA or other proteins in humans and animals which is used to identify diseases or the predisposition stage . The scope of this diagnostic comprises of the various clinical testing devices, supplies and reagents and which are used in hospitals, commercial laboratories, clinics, reference laboratories and research institutes for identifying disease indications for identifying and monitoring. Veterinary molecular diagnostics provides a number of benefits than the other traditional diagnostic techniques like fast shifting time (within 2.5–3 hours), high test specificity and sensitivity, and better distinction among the birulent and avirulant strains.

Get Sample Copy of Report Here: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-veterinary-molecular-diagnostics-market

Market Drivers:

·         Increase in the expenditure on pet animal

·         Increase in incidence of numerous animal diseases

·         Increase in the growth of foodborne diseases will act as a major market driver

Market Restraints:

·         High cost of these systems acts as a market restraint

·         Lack of trained professionals that can utilize completely antigen/immunogenic structures is also acting as a major market restraint

Leading Key players profiled in this report are:

Few of the major market competitors currently working in the veterinary molecular diagnostics market are IDEXX Laboratories, Inc., VCA, Inc., Abaxis, Heska Corporation , Zoetis , NEOGEN CORPORATION , Thermo Fisher Scientific, Inc., Virbac, General Electric Company, Agfa-Gevaert Group., Veterinary Molecular Diagnostics, Inc.,  Novacyt Group, Qiagen , Biomedica Medizinprodukte GmbH & Co KG, Veterinary Laboratory - HealthGene Corp. , Bioneer, Abaxis, Neogen Corporatio.

Global Veterinary Molecular Diagnostics Market Segmentation:

By Technology

·         PCR kits

o   RAPD-PCR strain analysis

o   Real Time PCR

·         INAAT kits

·         Microarray kits

·         DNA sequencing kits

By Product

·         Instruments & Software

·         Kits & Reagents

·         Services

By Animal Type

·         Companion Animals

·         Livestock Animals

By Disease Indication

·         Vector-borne Diseases

·         Respiratory Pathogens Detection

·         Diarrhea Pathogens Detection

·         Others

By Application

·         Infectious Diseases

·         Oncology

·         Genetics

·         Microbiology

By End-User

·         Veterinary Hospitals

·         Clinical Laboratories

·         Research Institutes

By Geography

·         North America

·         South America

·         Europe

·         Asia-Pacific

Competitive Analysis:

The global veterinary molecular diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of veterinary molecular diagnostics market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Get 20% Extra Discount for Early Buyer, Know More @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-veterinary-molecular-diagnostics-market

The Global Veterinary Molecular Diagnostics Market report provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading markets players within the Global Veterinary Molecular Diagnostics Market. The industry changing factors for the market segments are explored in this report.  This analysis report covers the growth factors of the worldwide market based on end-users. Market opportunities and recommendations for new investments are also encompassed in this report.

Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.

Contact:

Data Bridge Market Research

+1-888-387-2818

Find More Reports Related To This Category

Global Colposcopy Market

Global Cosmetic Pigments Market